7月3日，健康160盘中上涨10.38%，报10.33港元/股，成交额1753.94万港元。
消息面上，弗若斯特沙利文近期发布报告，按医院签约数与落地场景数计，认定健康160为中国AI医院运营服务商排名第一。截至4月末，公司"160AI医院"累计签约公立医疗机构120家，其中三级甲等医院66家占比55%，三级及以上医院合计97家占比80.8%。公司采用"SaaS订阅+按线上非医保项目GMV约10%分润"模式，标杆三甲案例中线上自费项目GMV月复合增长率达155.7%，分润闭环已初步跑通。此外，公司已于年初实现经调整净利润首次转正，数字医疗健康解决方案业务毛利率超80%，成为利润核心引擎。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.